EMEA (Europe, Middle East and Africa) Protein Drugs Market Report 2017

October 2017 | 115 pages | ID: EE5C77B28F8PEN
QYResearch

Abstracts

In this report, the EMEA Protein Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Protein Drugs for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Protein Drugs market competition by top manufacturers/players, with Protein Drugs sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Eli Lilly
• Abbott Laboratories
• UCB Group
• Schering-Plough Corporation
• Genentech
• Johnson'Johnson
• Bristol-Myers Squibb
• Novo Nordisk
• Biogen Idec
• Dendreon Corporation
• Amgen

On the basis of product, this report displays the sales volume (K Pcs), revenue (Million USD), product price (USD/Pcs), market share and growth rate of each type, primarily split into

• Antibody Drugs
• Peptide Hormones
• Blood Products
• Enzymes

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Pcs), market share and growth rate of Protein Drugs for each application, including

• AIDS
• Cancer
• Hepatitis
• Diabetes
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Protein Drugs Market Report 2017

1 PROTEIN DRUGS OVERVIEW

1.1 Product Overview and Scope of Protein Drugs
1.2 Classification of Protein Drugs
  1.2.1 EMEA Protein Drugs Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Protein Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Antibody Drugs
  1.2.4 Peptide Hormones
  1.2.5 Blood Products
  1.2.6 Enzymes
1.3 EMEA Protein Drugs Market by Application/End Users
  1.3.1 EMEA Protein Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 AIDS
  1.3.3 Cancer
  1.3.4 Hepatitis
  1.3.5 Diabetes
  1.3.6 Others
1.4 EMEA Protein Drugs Market by Region
  1.4.1 EMEA Protein Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Protein Drugs (2012-2022)
  1.5.1 EMEA Protein Drugs Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Protein Drugs Revenue and Growth Rate (2012-2022)

2 EMEA PROTEIN DRUGS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Protein Drugs Market Competition by Players/Manufacturers
  2.1.1 EMEA Protein Drugs Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Protein Drugs Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Protein Drugs Sale Price by Players (2012-2017)
2.2 EMEA Protein Drugs (Volume and Value) by Type/Product Category
  2.2.1 EMEA Protein Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Protein Drugs Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Protein Drugs Sale Price by Type (2012-2017)
2.3 EMEA Protein Drugs (Volume) by Application
2.4 EMEA Protein Drugs (Volume and Value) by Region
  2.4.1 EMEA Protein Drugs Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Protein Drugs Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Protein Drugs Sales Price by Region (2012-2017)

3 EUROPE PROTEIN DRUGS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Protein Drugs Sales and Value (2012-2017)
  3.1.1 Europe Protein Drugs Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Protein Drugs Revenue and Growth Rate (2012-2017)
3.2 Europe Protein Drugs Sales and Market Share by Type
3.3 Europe Protein Drugs Sales and Market Share by Application
3.4 Europe Protein Drugs Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Protein Drugs Sales Volume by Countries (2012-2017)
  3.4.2 Europe Protein Drugs Revenue by Countries (2012-2017)
  3.4.3 Germany Protein Drugs Sales and Growth Rate (2012-2017)
  3.4.4 France Protein Drugs Sales and Growth Rate (2012-2017)
  3.4.5 UK Protein Drugs Sales and Growth Rate (2012-2017)
  3.4.6 Russia Protein Drugs Sales and Growth Rate (2012-2017)
  3.4.7 Italy Protein Drugs Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Protein Drugs Sales and Growth Rate (2012-2017)

4 MIDDLE EAST PROTEIN DRUGS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Protein Drugs Sales and Value (2012-2017)
  4.1.1 Middle East Protein Drugs Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Protein Drugs Revenue and Growth Rate (2012-2017)
4.2 Middle East Protein Drugs Sales and Market Share by Type
4.3 Middle East Protein Drugs Sales and Market Share by Application
4.4 Middle East Protein Drugs Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Protein Drugs Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Protein Drugs Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Protein Drugs Sales and Growth Rate (2012-2017)
  4.4.4 Israel Protein Drugs Sales and Growth Rate (2012-2017)
  4.4.5 UAE Protein Drugs Sales and Growth Rate (2012-2017)
  4.4.6 Iran Protein Drugs Sales and Growth Rate (2012-2017)

5 AFRICA PROTEIN DRUGS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Protein Drugs Sales and Value (2012-2017)
  5.1.1 Africa Protein Drugs Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Protein Drugs Revenue and Growth Rate (2012-2017)
5.2 Africa Protein Drugs Sales and Market Share by Type
5.3 Africa Protein Drugs Sales and Market Share by Application
5.4 Africa Protein Drugs Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Protein Drugs Sales Volume by Countries (2012-2017)
  5.4.2 Africa Protein Drugs Revenue by Countries (2012-2017)
  5.4.3 South Africa Protein Drugs Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Protein Drugs Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Protein Drugs Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Protein Drugs Sales and Growth Rate (2012-2017)

6 EMEA PROTEIN DRUGS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Eli Lilly
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Protein Drugs Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Eli Lilly Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Abbott Laboratories
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Protein Drugs Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Abbott Laboratories Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 UCB Group
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Protein Drugs Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 UCB Group Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Schering-Plough Corporation
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Protein Drugs Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Schering-Plough Corporation Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Genentech
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Protein Drugs Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Genentech Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Johnson?Johnson
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Protein Drugs Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Johnson?Johnson Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Bristol-Myers Squibb
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Protein Drugs Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Bristol-Myers Squibb Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Novo Nordisk
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Protein Drugs Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Novo Nordisk Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Biogen Idec
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Protein Drugs Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Biogen Idec Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Dendreon Corporation
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Protein Drugs Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Dendreon Corporation Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Amgen

7 PROTEIN DRUGS MANUFACTURING COST ANALYSIS

7.1 Protein Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Protein Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Protein Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Protein Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA PROTEIN DRUGS MARKET FORECAST (2017-2022)

11.1 EMEA Protein Drugs Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Protein Drugs Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Protein Drugs Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Protein Drugs Price and Trend Forecast (2017-2022)
11.2 EMEA Protein Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Protein Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Protein Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Protein Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Protein Drugs Sales Forecast by Type (2017-2022)
11.7 EMEA Protein Drugs Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Protein Drugs
Figure EMEA Protein Drugs Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Protein Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Antibody Drugs Product Picture
Figure Peptide Hormones Product Picture
Figure Blood Products Product Picture
Figure Enzymes Product Picture
Figure EMEA Protein Drugs Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Protein Drugs by Application in 2016
Figure AIDS Examples
Table Key Downstream Customer in AIDS
Figure Cancer Examples
Table Key Downstream Customer in Cancer
Figure Hepatitis Examples
Table Key Downstream Customer in Hepatitis
Figure Diabetes Examples
Table Key Downstream Customer in Diabetes
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Protein Drugs Market Size (Million USD) by Region (2012-2022)
Figure Europe Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Protein Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Protein Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Africa Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Protein Drugs Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Protein Drugs Sales Volume and Growth Rate (2012-2022)
Figure EMEA Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Protein Drugs Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Protein Drugs Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Protein Drugs Sales Share by Players (2012-2017)
Figure 2016 Protein Drugs Sales Share by Players
Figure 2017 Protein Drugs Sales Share by Players
Figure EMEA Protein Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Protein Drugs Revenue (Million USD) by Players (2012-2017)
Table EMEA Protein Drugs Revenue Share by Players (2012-2017)
Table 2016 EMEA Protein Drugs Revenue Share by Players
Table 2017 EMEA Protein Drugs Revenue Share by Players
Table EMEA Protein Drugs Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Protein Drugs Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Protein Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Protein Drugs by Type (2012-2017)
Figure EMEA Protein Drugs Sales Market Share by Type (2012-2017)
Table EMEA Protein Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Protein Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Protein Drugs by Type in 2016
Table EMEA Protein Drugs Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Protein Drugs Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Protein Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Protein Drugs by Application (2012-2017)
Figure EMEA Protein Drugs Sales Market Share by Application in 2016
Table EMEA Protein Drugs Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Protein Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Protein Drugs by Region (2012-2017)
Figure EMEA Protein Drugs Sales Market Share in 2016
Table EMEA Protein Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Protein Drugs Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Protein Drugs by Region (2012-2017)
Figure EMEA Protein Drugs Revenue Market Share Regions in 2016
Table EMEA Protein Drugs Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Protein Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Protein Drugs Revenue and Growth Rate (2012-2017)
Table Europe Protein Drugs Sales (K Pcs) by Type (2012-2017)
Table Europe Protein Drugs Market Share by Type (2012-2017)
Figure Europe Protein Drugs Market Share by Type in 2016
Table Europe Protein Drugs Sales (K Pcs) by Application (2012-2017)
Table Europe Protein Drugs Market Share by Application (2012-2017)
Figure Europe Protein Drugs Market Share by Application in 2016
Table Europe Protein Drugs Sales (K Pcs) by Countries (2012-2017)
Table Europe Protein Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Protein Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Protein Drugs Sales Market Share by Countries in 2016
Table Europe Protein Drugs Revenue (Million USD) by Countries (2012-2017)
Table Europe Protein Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Protein Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Protein Drugs Revenue Market Share by Countries in 2016
Figure Germany Protein Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Protein Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Protein Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Protein Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Protein Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Protein Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Protein Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Protein Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Protein Drugs Sales (K Pcs) by Type (2012-2017)
Table Middle East Protein Drugs Market Share by Type (2012-2017)
Figure Middle East Protein Drugs Market Share by Type (2012-2017)
Table Middle East Protein Drugs Sales (K Pcs) by Applications (2012-2017)
Table Middle East Protein Drugs Market Share by Applications (2012-2017)
Figure Middle East Protein Drugs Sales Market Share by Application in 2016
Table Middle East Protein Drugs Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Protein Drugs Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Protein Drugs Sales Volume Market Share by Countries in 2016
Table Middle East Protein Drugs Revenue (Million USD) by Countries (2012-2017)
Table Middle East Protein Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Protein Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Protein Drugs Revenue Market Share by Countries in 2016
Figure Saudi Arabia Protein Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Protein Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Protein Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Protein Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Protein Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Protein Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Protein Drugs Sales (K Pcs) by Type (2012-2017)
Table Africa Protein Drugs Sales Market Share by Type (2012-2017)
Figure Africa Protein Drugs Sales Market Share by Type (2012-2017)
Figure Africa Protein Drugs Sales Market Share by Type in 2016
Table Africa Protein Drugs Sales (K Pcs) by Application (2012-2017)
Table Africa Protein Drugs Sales Market Share by Application (2012-2017)
Figure Africa Protein Drugs Sales Market Share by Application (2012-2017)
Table Africa Protein Drugs Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Protein Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Protein Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Protein Drugs Sales Market Share by Countries in 2016
Table Africa Protein Drugs Revenue (Million USD) by Countries (2012-2017)
Table Africa Protein Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Protein Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Protein Drugs Revenue Market Share by Countries in 2016
Figure South Africa Protein Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Protein Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Protein Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Protein Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Table Eli Lilly Protein Drugs Basic Information List
Table Eli Lilly Protein Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Eli Lilly Protein Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Eli Lilly Protein Drugs Sales Market Share in EMEA (2012-2017)
Figure Eli Lilly Protein Drugs Revenue Market Share in EMEA (2012-2017)
Table Abbott Laboratories Protein Drugs Basic Information List
Table Abbott Laboratories Protein Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Abbott Laboratories Protein Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Abbott Laboratories Protein Drugs Sales Market Share in EMEA (2012-2017)
Figure Abbott Laboratories Protein Drugs Revenue Market Share in EMEA (2012-2017)
Table UCB Group Protein Drugs Basic Information List
Table UCB Group Protein Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure UCB Group Protein Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure UCB Group Protein Drugs Sales Market Share in EMEA (2012-2017)
Figure UCB Group Protein Drugs Revenue Market Share in EMEA (2012-2017)
Table Schering-Plough Corporation Protein Drugs Basic Information List
Table Schering-Plough Corporation Protein Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Schering-Plough Corporation Protein Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Schering-Plough Corporation Protein Drugs Sales Market Share in EMEA (2012-2017)
Figure Schering-Plough Corporation Protein Drugs Revenue Market Share in EMEA (2012-2017)
Table Genentech Protein Drugs Basic Information List
Table Genentech Protein Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Genentech Protein Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Genentech Protein Drugs Sales Market Share in EMEA (2012-2017)
Figure Genentech Protein Drugs Revenue Market Share in EMEA (2012-2017)
Table Johnson?Johnson Protein Drugs Basic Information List
Table Johnson?Johnson Protein Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Johnson?Johnson Protein Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Johnson?Johnson Protein Drugs Sales Market Share in EMEA (2012-2017)
Figure Johnson?Johnson Protein Drugs Revenue Market Share in EMEA (2012-2017)
Table Bristol-Myers Squibb Protein Drugs Basic Information List
Table Bristol-Myers Squibb Protein Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Protein Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Protein Drugs Sales Market Share in EMEA (2012-2017)
Figure Bristol-Myers Squibb Protein Drugs Revenue Market Share in EMEA (2012-2017)
Table Novo Nordisk Protein Drugs Basic Information List
Table Novo Nordisk Protein Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novo Nordisk Protein Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Novo Nordisk Protein Drugs Sales Market Share in EMEA (2012-2017)
Figure Novo Nordisk Protein Drugs Revenue Market Share in EMEA (2012-2017)
Table Biogen Idec Protein Drugs Basic Information List
Table Biogen Idec Protein Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Biogen Idec Protein Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Biogen Idec Protein Drugs Sales Market Share in EMEA (2012-2017)
Figure Biogen Idec Protein Drugs Revenue Market Share in EMEA (2012-2017)
Table Dendreon Corporation Protein Drugs Basic Information List
Table Dendreon Corporation Protein Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Dendreon Corporation Protein Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Dendreon Corporation Protein Drugs Sales Market Share in EMEA (2012-2017)
Figure Dendreon Corporation Protein Drugs Revenue Market Share in EMEA (2012-2017)
Table Amgen Protein Drugs Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Protein Drugs
Figure Manufacturing Process Analysis of Protein Drugs
Figure Protein Drugs Industrial Chain Analysis
Table Raw Materials Sources of Protein Drugs Major Manufacturers in 2016
Table Major Buyers of Protein Drugs
Table Distributors/Traders List
Figure EMEA Protein Drugs Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Protein Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Protein Drugs Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Protein Drugs Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Protein Drugs Sales Market Share Forecast by Region (2017-2022)
Table EMEA Protein Drugs Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Protein Drugs Revenue Market Share Forecast by Region (2017-2022)
Table Europe Protein Drugs Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Protein Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Europe Protein Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Protein Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Protein Drugs Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Protein Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Protein Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Protein Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Protein Drugs Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Protein Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Africa Protein Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Protein Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Protein Drugs Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Protein Drugs Sales Market Share Forecast by Type (2017-2022)
Table EMEA Protein Drugs Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Protein Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources